Companies: 10,795·Total market cap: $144.5T
bioMérieux S.A.

bioMérieux S.A.

BMXXYOTCHealthcare● Active
$8.43
$-1.72(-16.95%)
Market Cap$9.9B
P/E Ratio
52W High$14.62
52W Low$7.9075
Overview

bioMérieux S.A. (BMXXY) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · BMXXY · as of Jun 8, 2026

Key Statistics

EPS (TTM)$0.70bmxxy eps ttm · bmxxy earnings per shareEarnings history
PE Ratio (TTM)12.0×bmxxy pe ratio ttm · bmxxy price to earningsPE Ratio deep dive
Revenue (TTM)$8.0Bbmxxy revenue ttm · bmxxy annual revenueFull revenue history
Dividend Yield1.35%does bmxxy pay dividends · bmxxy dividend yieldDividend history
Shares Outstanding1.18Bbmxxy shares outstanding · bmxxy floatShares outstanding history
Next EarningsTBAbmxxy earnings date · bmxxy next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$3.91B▼ 1.78% YoY
202320242025
biomérieux s.a. revenue · bmxxy revenue 2025
FY 2025Net Income$381.8M▼ 11.66% YoY
202320242025
biomérieux s.a. net income · bmxxy profit 2025
FY 2025EPS$0.32▼ 13.51% YoY
202320242025
bmxxy eps · biomérieux s.a. earnings per share 2025
TTM:Revenue: $8.03BNet Income: $827.8MEPS: $0.70View income statement →

Stock Performance

Full History
1D-16.95%
1W-7.36%
1M+6.04%
3M-42.06%
YTD-33.10%
1Y-34.90%
5Y-91.65%

About bioMérieux S.A.

CEOPierre Boulud
IPO DateJun 9, 2023
Employees14,147
CountryFR

bioMérieux S.A. is a global leader in the development and production of in vitro diagnostic solutions, primarily aimed at detecting infectious diseases. Its operations span the Americas, Europe, the M…

what is biomérieux s.a. · bmxxy stock overview · biomérieux s.a. company profile · who is biomérieux s.a. ceo · bmxxy OTC · biomérieux s.a. headquarters · biomérieux s.a. business segments

About Stock Overview & Key Data

bioMérieux S.A. (BMXXY) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on OTC since Jun 9, 2023. As of the latest trading session, BMXXY stock price is $8.43, with a market capitalization of $9.9B. The stock has returned -34.90% over the past 12 months and -33.10% year-to-date.

In fiscal year 2025, bioMérieux S.A. reported revenue of $3.9B. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.

Frequently Asked Questions

As of the latest trading session, bioMérieux S.A. (BMXXY) stock price is $8.43. The stock is traded on OTC under the ticker symbol BMXXY. The 52-week range is $7.91 – $14.62.

BMXXY stock priceBMXXY quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice